Ionis Pharmaceuticals
IONS
IONS
301 hedge funds and large institutions have $5.84B invested in Ionis Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 103 increasing their positions, 89 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
2.47% more ownership
Funds ownership: 90.11% → 92.58% (+2.5%)
3% more capital invested
Capital invested by funds: $5.68B → $5.84B (+$155M)
17% less call options, than puts
Call options by funds: $71.6M | Put options by funds: $86.1M
Holders
301
Holding in Top 10
7
Calls
$71.6M
Puts
$86.1M
Top Buyers
| 1 | +$46.4M | |
| 2 | +$43.7M | |
| 3 | +$26.7M | |
| 4 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
+$25.7M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$22.8M |
Top Sellers
| 1 | -$30.3M | |
| 2 | -$24.3M | |
| 3 | -$19.7M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$9.9M |
| 5 |
AG
Artal Group
Luxembourg
|
-$6.87M |